CRIS drug approved

CRIS received an early approval of vismodegib this morning (PDUFA date was March 6th). It was never my intention to hold through approval/CRL, but these surprises are what keep things interesting. Anyway, I disposed of 75% of my position at $5. Missed the quick spike to $5.65 and waited for a recovery from the subsequent dive. I will hold onto the remaining shares with a stop of $4.60. CRIS generated a 38% return on the portion I off-loaded.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s